ArticleCureus2016

KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer.

Arturo Loaiza-Bonilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.